MILLS CHRISTOPHER H B

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 71% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
MILLS CHRISTOPHER H B's trades of Renalytix PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Renalytix PLC (RENX)
Transaction date
Sale
Price
111.61
Quantity 46,422
Value £4,394,202
Transaction date
Sale
Price
271.52
Quantity 52,762 -48.2%
Value US$3,642,837
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-01 2026-09-29
US Renalytix PLC (RENX)
S Sale
46,422
111.61
£4,394,202 		46,422 111.61 £4,394,202
2026-08-04 2026-07-30
B Purchase
68,594
128.92
£3,687,652 		68,594 128.92 £3,687,652
2021-03-17 2021-03-16
S Sale
52,762 -48.2%
271.52
US$3,642,837 		52,762 -48.2% 271.52 US$3,642,837
2021-02-25 2021-02-23
S Sale
30,912 -100.0%
1.96
US$60,495 		30,912 -100.0% 1.96 US$60,495
2021-02-25 2021-02-22
S Sale
500,000 -94.2%
2.93
US$1,464,050 		500,000 -94.2% 2.93 US$1,464,050
2021-02-25 2021-02-19
S Sale
221,326 -29.4%
2.32
US$512,480 		221,326 -29.4% 2.32 US$512,480
2021-02-25 2021-02-18
S Sale
44,308 -5.6%
2.33
US$103,317 		44,308 -5.6% 2.33 US$103,317